Description of Business Maravai LifeSciences Holdings, Inc. (also referred to in this document as Maravai, we, us, our or the Company) is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Our customers include biopharmaceutical companies, emerging biotech firms, life science research organizations, academic research institutions and diagnostics companies. Our compreh...
Q2 FY2026 — expected 2026-08-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001823239-26-000011 | EDGAR | 84K words |
| 2025-03-18 | 2024-12-31 | 0001823239-25-000034 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0001823239-24-000032 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0001823239-23-000014 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001823239-22-000012 | EDGAR | — |
| 2021-03-22 | 2020-12-31 | 0001823239-21-000006 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-07 | 2025-09-30 | 0001823239-25-000120 | EDGAR | 36K words |
| 2025-08-11 | 2025-06-30 | 0001823239-25-000107 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001823239-25-000063 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001823239-24-000118 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001823239-24-000095 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001823239-24-000060 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001823239-23-000089 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001823239-23-000081 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001823239-23-000039 | EDGAR | — |
| 2022-11-04 | 2022-09-30 | 0001823239-22-000058 | EDGAR | — |
| 2022-08-05 | 2022-06-30 | 0001823239-22-000044 | EDGAR | — |
| 2022-05-06 | 2022-03-31 | 0001823239-22-000018 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-25 | 0001823239-26-000005 | EDGAR | 6K words |
| 2025-11-06 | 0001823239-25-000117 | EDGAR | — |
| 2025-10-27 | 0001823239-25-000113 | EDGAR | — |
| 2025-08-11 | 0001823239-25-000105 | EDGAR | — |
| 2025-07-18 | 0001823239-25-000099 | EDGAR | — |
| 2025-06-25 | 0001193125-25-146905 | EDGAR | — |
| 2025-06-09 | 0001193125-25-137478 | EDGAR | — |
| 2025-05-28 | 0001823239-25-000065 | EDGAR | — |
| 2025-05-12 | 0001823239-25-000062 | EDGAR | — |
| 2025-03-20 | 0001823239-25-000059 | EDGAR | — |
83 total filings indexed. 55 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001823239 |
| Ticker | MRVI |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.maravai.com |
| Listed | 2020-11-20 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report